Literature DB >> 29947731

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

P Quaglino1, M Maule1, H M Prince1, P Porcu1, S Horwitz1, M Duvic1, R Talpur1, M Vermeer1, M Bagot1, J Guitart1, E Papadavid1, J A Sanches1, E Hodak1, M Sugaya1, E Berti1, P Ortiz-Romero1, N Pimpinelli1, O Servitje1, A Pileri1, P L Zinzani1, T Estrach1, R Knobler1, R Stadler1, M T Fierro1, S Alberti Violetti1, I Amitay-Laish1, C Antoniou1, C Astrua1, S Chaganti1, F Child1, A Combalia1, S Fabbro1, P Fava1, V Grandi1, C Jonak1, E Martinez-Escala1, M Kheterpal1, E J Kim1, C McCormack1, T Miyagaki1, D Miyashiro1, S Morris1, C Muniesa1, V Nikolaou1, G Ognibene1, F Onida1, S Osella-Abate1, S Porkert1, C Postigo-Llorente1, C Ram-Wolff1, S Ribero1, K Rogers1, M Sanlorenzo1, R Stranzenbach1, N Spaccarelli1, A Stevens1, D Zugna1, A H Rook1, L J Geskin1, R Willemze1, S Whittaker1, R Hoppe1, J Scarisbrick1, Y Kim1.   

Abstract

Entities:  

Year:  2019        PMID: 29947731     DOI: 10.1093/annonc/mdy207

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center.

Authors:  Yumeng Zhang; Lucia Seminario-Vidal; Christa Varnadoe; Yuanyuan Lu; Ning Dong; Christopher Salamanca; Shannen Whiddon; Janice Bennett; Rebecca Hargis; Hien Liu; Michael Montejo; Mohammad Hussaini; Carly Harro; Jane Messina; Kaaron Benson; Javier Pinilla-Ibarz; Jose Conejo-Garcia; Lubomir Sokol
Journal:  Leuk Lymphoma       Date:  2021-09-01

2.  Mycosis fungoides and Sézary syndrome.

Authors:  Constanze Jonak; Julia Tittes; Patrick Manfred Brunner; Emmanuella Guenova
Journal:  J Dtsch Dermatol Ges       Date:  2021-09       Impact factor: 5.231

Review 3.  Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.

Authors:  Pan Lai; Yang Wang
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

4.  Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review.

Authors:  Chao Chen; Zhaorui Liu; Jie Liu; Wei Zhang; Daobin Zhou; Yan Zhang
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.